verapamil has been researched along with Heart Defects, Congenital in 19 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
Excerpt | Relevance | Reference |
---|---|---|
"Verapamil was administered intravenously to 250 patients aged between 14 and 85, suffering from tachyarrhythmia of various type." | 7.65 | [Clinical results with verapamil in intravenous administration in the emergency therapy of cardiac arrhythmias]. ( Amoroso, A, 1975) |
"Verapamil was administered intravenously to 250 patients aged between 14 and 85, suffering from tachyarrhythmia of various type." | 3.65 | [Clinical results with verapamil in intravenous administration in the emergency therapy of cardiac arrhythmias]. ( Amoroso, A, 1975) |
"Twenty-five VTs showed right bundle branch block morphology and 23 left bundle branch block morphology, and VT was entrained in 84 and 96%, respectively." | 1.29 | Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease. ( Aizawa, Y; Kitazawa, H; Kusano, Y; Naitoh, N; Shibata, A; Uchiyama, H; Washizuka, T, 1993) |
"Verapamil was used in one infant with AV node reentry tachycardia." | 1.29 | Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. ( Saul, JP; Walsh, EP; Weindling, SN, 1996) |
"Supraventricular tachycardia is one of the most frequent arrhythmias in childhood." | 1.27 | [Supraventricular tachycardia in children]. ( Attanà, A; Battaglia, T; Caristo, S; Ciconte, V; Fumarulo, A; Martini, B; Paparo, F, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (63.16) | 18.7374 |
1990's | 5 (26.32) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tang, C | 1 |
Luo, C | 1 |
Hua, Y | 1 |
Zhou, K | 1 |
Duan, H | 1 |
Ma, F | 1 |
Zhang, Y | 1 |
Li, Y | 1 |
Qiu, D | 1 |
Wang, C | 1 |
Kazanskaia, GM | 1 |
Volkov, AM | 1 |
D'iakonitsa, TM | 1 |
Zhdanov, GP | 1 |
Gracián Gómez, M | 1 |
Rodríguez Caamaño, J | 1 |
Guía Torrent, JM | 1 |
Battaglia, T | 1 |
Paparo, F | 1 |
Fumarulo, A | 1 |
Attanà, A | 1 |
Ciconte, V | 1 |
Caristo, S | 1 |
Martini, B | 1 |
Leitner, RP | 1 |
Hawker, RE | 1 |
Celermajer, JM | 1 |
Aizawa, Y | 1 |
Naitoh, N | 1 |
Kitazawa, H | 1 |
Kusano, Y | 1 |
Uchiyama, H | 1 |
Washizuka, T | 1 |
Shibata, A | 1 |
Weindling, SN | 1 |
Saul, JP | 1 |
Walsh, EP | 1 |
Gabbarini, F | 1 |
Amino, JG | 1 |
Studart, PC | 1 |
de Brito, AH | 1 |
Brando, PR | 1 |
Maia, IG | 1 |
Almeida, G | 1 |
Dohmann, HJ | 1 |
Amoroso, A | 1 |
Binder, LS | 1 |
Boeche, R | 1 |
Atkinson, D | 1 |
Jaffee, OC | 1 |
Jaffee, AL | 1 |
Takagi, Y | 1 |
Bruyere, HJ | 2 |
Nishikawa, T | 2 |
Kajita, A | 1 |
Ando, M | 1 |
Takao, A | 1 |
Gilbert, EF | 1 |
Bolens, M | 1 |
Friedli, B | 1 |
Deom, A | 1 |
Hirsch, IA | 1 |
Zauder, HL | 1 |
Barousch, R | 1 |
Storstein, O | 1 |
Rasmussen, K | 1 |
Rudolph, W | 1 |
Kriener, J | 1 |
Meister, W | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Intranasal Dexmedetomidine vs Oral Triclofos Sodium Sedation for Children With Autism Undergoing Electroencephalograms - A Randomized Controlled Trial.[NCT04270708] | Phase 4 | 200 participants (Anticipated) | Interventional | 2020-03-01 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for verapamil and Heart Defects, Congenital
Article | Year |
---|---|
[Recent advances and future perspectives in the medical treatment of cardiopathies in children].
Topics: Child; Ductus Arteriosus, Patent; Heart Defects, Congenital; Heart Failure; Humans; Hypoxia; Indomet | 1984 |
18 other studies available for verapamil and Heart Defects, Congenital
Article | Year |
---|---|
Placental P-glycoprotein inhibition enhances susceptibility to Di-(2-ethylhexyl)-phthalate induced cardiac malformations in mice: A possibly promising target for congenital heart defects prevention.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Diethylhexyl Phthalate; Female; Fe | 2019 |
[Endothelium of myocardium microvessel under conditions of hypothermia, ischemia, reperfusion and pharmaco-cold cardioplegia with calcium antagonist].
Topics: Calcium Channel Blockers; Cardioplegic Solutions; Coronary Vessels; Endothelium, Vascular; Heart Atr | 2005 |
[Supraventricular tachycardia in children].
Topics: Adenosine Triphosphate; Amiodarone; Cardiac Pacing, Artificial; Child; Digitalis Glycosides; Heart D | 1983 |
Intravenous verapamil in the treatment of paroxysmal supraventricular tachycardia in children.
Topics: Adolescent; Child; Child, Preschool; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Inj | 1983 |
Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease.
Topics: Adolescent; Adult; Bundle of His; Bundle-Branch Block; Cardiac Pacing, Artificial; Cardiomyopathy, D | 1993 |
Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants.
Topics: Anti-Arrhythmia Agents; Catheter Ablation; Digoxin; Electrocardiography; Esophagus; Female; Follow-U | 1996 |
A 61-year-old man with Holmes' heart.
Topics: Amlodipine; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiac Output, Low; Heart Defects, Con | 1999 |
[Action of verapamil on the dynamics of heart conduction].
Topics: Adolescent; Adult; Child; Drug Evaluation; Female; Heart Conduction System; Heart Defects, Congenita | 1977 |
[Clinical results with verapamil in intravenous administration in the emergency therapy of cardiac arrhythmias].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Coronary Disease; Female; Heart | 1975 |
Evaluation and management of supraventricular tachycardia in children.
Topics: Anemia; Dehydration; Dopamine; Electric Countershock; Fluid Therapy; Heart Defects, Congenital; Huma | 1991 |
Ectopia cordis in the chick embryo heart: an experimental study.
Topics: Animals; Chick Embryo; Embryonic and Fetal Development; Heart Defects, Congenital; Ovalbumin; Verapa | 1990 |
Protective effect of ouabain on adriamycin-induced cardiovascular anomalies in chick embryos.
Topics: Animals; Chick Embryo; Coenzymes; Dose-Response Relationship, Drug; Doxorubicin; Heart; Heart Defect | 1989 |
Potentiating effects of verapamil on cardiovascular teratogenicity of phenobarbital in the chick embryos.
Topics: Abnormalities, Drug-Induced; Animals; Aorta; Calcium; Chick Embryo; Drug Synergism; Heart Defects, C | 1988 |
Electrophysiologic effects of intravenous verapamil in children after operations for congenital heart disease.
Topics: Adolescent; Child; Child, Preschool; Electrophysiology; Heart Conduction System; Heart Defects, Cong | 1987 |
Chloral hydrate: a potential cause of arrhythmias.
Topics: Child; Child, Preschool; Chloral Hydrate; Digoxin; Female; Heart Defects, Congenital; Humans; Infant | 1986 |
[The treatment of heart arrhythmia with the heart sympatholytic iproveratril].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Com | 1967 |
Digitalis and atrial tachycardia with block.
Topics: Adult; Aged; Coronary Disease; Digitoxin; Electric Countershock; Electrocardiography; Female; Heart | 1974 |
[Effect of verapamil on coronary blood flow, oxygen utilisation and carbon dioxide production in human heart].
Topics: Carbon Dioxide; Coronary Vessels; Electrocardiography; Heart; Heart Defects, Congenital; Heart Disea | 1971 |